The venture boom that funneled billions of dollars into life sciences companies last year included a big surge in first-time deals, according to a fresh analysis of the numbers for 2014. And the boom in venture investing looks set to continue well into 2015, according to the analysts at PricewaterhouseCoopers and the National Venture Capital Association, working with data provided by Thomson Reuters to put out the MoneyTree report.
{iframe}http://www.fiercebiotech.com/story/biotech-boom-drives-blockbuster-vc-investments-boston-san-francisco/2015-02-13{/iframe}